arrow
W

Woong Chol Kang

gachon university
H指数:29
被引数:4,746

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and Safety of Fimasartan, Atorvastatin, and Ezetimibe Combination Therapy in Patients With Hypertension and Dyslipidemia: A Randomized, Double-Blind, Multicenter, Therapeutic Confirmatory, Phase III Clinical Trial

替尔泊肽、阿托伐他汀和依泽替麦组合疗法在高血压和高脂血症患者中的疗效与安全性:一项随机、双盲、多中心、治疗确证性、III期临床试验

2025-09-140
PREAI
Long-term outcomes of intravascular ultrasound-guided percutaneous coronary intervention versus coronary artery bypass grafting for multivessel coronary artery disease

多支血管冠状动脉疾病中,血管内超声引导的经皮冠状动脉介入治疗与冠状动脉旁路移植术的长期结局比较

HEART
IF4.4
2025-05-140
PRE
Effect of rosuvastatin versus atorvastatin on new-onset diabetes mellitus in patients treated with high-intensity statin therapy for coronary artery disease: a post-hoc analysis from the LODESTAR randomized clinical trial
2024-08-070
OAAI
Comparison of 7-Year, Real-World Clinical Outcomes between Drug-Coated Balloon Angioplasty versus Drug-Eluting Stent Implantation in Patients with Drug-Eluting Stent In-Stent Restenosis

药物涂层球囊血管成形术与药物洗脱支架植入术治疗药物洗脱支架内再狭窄患者7年真实临床结果比较

2023-06-241
OAAI
Early Invasive Strategy Based on the Time of Symptom Onset of Non-ST-Segment Elevation Myocardial Infarction
2023-01-015
OAAI
Moderate-intensity statin with ezetimibe vs. high-intensity statin in patients with diabetes and atherosclerotic cardiovascular disease in the RACING trial

中等强度他汀类药物联合依泽替米贝与高强度他汀类药物在糖尿病和动脉粥样硬化性心血管疾病患者中的RACING试验

2022-12-1929
OA
Everolimus-Eluting Stents or Bypass Surgery for Multivessel Coronary Artery Disease: Extended Follow-Up Outcomes of Multicenter Randomized Controlled BEST Trial
2022-11-2218
OA
Long-Term Clinical Outcomes and Its Predictors Between the 1-and 2-Stent Strategy in Coronary Bifurcation Lesions ? A Baseline Clinical and Lesion Characteristic-Matched Analysis ?
2022-08-254
OA